Search results
Author(s):
Federico M Asch
Added:
3 years ago
Dr Federico M Asch (MedStar Health Research Institute, Georgetown University, Washington DC, WA, US) discusses the latest findings from the Global EXPAND Study. Their research looked into mitral valve leaflet events with MitraClip (NTR/XTR).
Questions:
1. Can you briefly remind us what the EXPAND registry is and what it assesses?
2. What research have you conducted on leaflet adverse…
View more
Author(s):
Antonio Popolo Rubbio
Added:
1 year ago
In this short video, Dr Antonio Popolo Rubbio (IRCCS Policlinico San Donato, IT) shares the key findings from a study that assessed the use of the MitraClip in patients with atrial functional mitral regurgitation.
Discussion Points
1. Study Background
2. Mitraclip Procedure
3. Study Design & the Patient Selection Criteria
4. Key Findings
5. Which Patients Would Benefit the Most from this…
View more
Author(s):
Khung Keong Yeo
,
Jack Wei Chieh Tan
,
David WM Muller
,
et al
Added:
2 years ago
Author(s):
Kashish Goel
,
Colin M Barker
,
JoAnn Lindenfeld
Added:
3 years ago
Heart failure (HF) is a growing epidemic, with an estimated 6.2 million adults (≥20 years) affected between 2013 and 2016 in the US.1 The prevalence is increasing and is expected to reach 8 million by 2030.1 Mitral regurgitation (MR) is common in HF patients, especially in those with ischaemia, left ventricular (LV) dysfunction or dilated cardiomyopathy. MR in the absence of structural…
View more
Author(s):
Eduardo Alegria-Barrero
,
Olaf W Franzen
Added:
3 years ago
Diseases of the mitral valve (MV) are the second most frequent clinically significant form of valvular disease in adults. In particular, MV regurgitation occurs with increasing frequency as part of degenerative changes in the ageing process.1
The annual incidence of degenerative MV disease is estimated at approximately 2–3 %. In addition to degenerative valve disease, MV regurgitation can be…
View more
Author(s):
Antoni Bayés-Genís
Added:
3 years ago
“Science can amuse and fascinate us all, but it is engineering that changes the world.”
– Isaac Asimov, 1920–1992
Technological breakthroughs, particularly advances in devices, are changing the course of heart failure (HF) management. Implantable devices have been used for decades to treat heart disease. The first pacemaker was implanted over 60 years ago (October 1958), and implantable…
View more
Gilbert Tang
Author
Sam Dawkins
Job title: Consultant Cardiologist
Author
Michael J Mullen
Job title: Consultant Interventional Cardiologist
Author
Jaffar M Khan
Job title: Staff Clinician
Author